Company profile
UNITEDHEALTH GROUP INC
NYSE:UNHMedical Specialities
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT04353037 | phase2 | terminated | 2020-04-07 | 2020-07-11 | UnitedHealth Group | PATCH 2&3:Prevention & Treatment of COVID-19 (Severe Acute Respiratory Syndrome Coronavirus 2) With Hydroxychloroquine |
FDA applications (0)
No records yet.